Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2016-06-01
2017-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives and Purpose The general purpose of this project is to compare a new preoxygenation technique based on humidified oxygen in a high-flow nasal cannula with traditional preoxygenation with a tight fitting mask during rapid sequence induction intubation with focus on gas exchange.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The patients will undergo regular pre-anesthetic evaluation and will be then be asked to participate in the study. Oral and written information will be given. A consent form will be signed.
The patients will be randomized to either traditional preoxygenation or preoxygenation with high-flow nasal cannula (HFNC) oxygen.
On arrival in the operating room standard patient monitoring will be applied (ECG, pulse oximetry, non-invasive blood pressure) and preparation for anesthesia induction will be done with the patients placed with a slightly elevated head, approximately 25º. Peripheral oxygen saturation (SpO2) will be noted when breathing room air. If an arterial line is planned this will be put in place before pre-oxygenation and a blood sample will be drawn when breathing room air Preoxygenation will hereafter take place either the traditional way or with a HFNC. The traditional preoxygenation consists of breathing 100% oxygen via a tight-fitting non-rebreathing facial mask with a fresh gas flow of ≥10 L/min of for ≥ 3 minutes. HFNC pre-oxygenation consists of application of nasal cannulae (Optiflow TM, Fisher \& Paykel Healthcare, Auckland, New Zealand) in the nostrils and the patients will receive 40L/min of heated and humidified 100% oxygen for ≥ 3 minutes.
After induction of anesthesia with RSI the airways will be kept open by manual adjustment by the anesthesiologist until intubation regardless of pre-oxygenation technique. During the laryngoscopy and intubation 70L/min of humidified 100% oxygen will be administered continuously by the nasal cannula left in place if HFNC oxygen is used.
Endtidal carbon dioxide (ETCO2) will be noted before the start of pre-oxygenation and on the first breath after intubation. If an arterial line is in place blood gas samples will be taken before the start of pre-oxygenation (breathing room air) and when the endotracheal tube is in place.
Output data:
* SpO2 breathing room air, at end of pre-oxygenation and one minute after intubation
* ETCO2 before pre-oxygenation and at first breath after intubation
* Time to intubation (measured from start of laryngoscopy to when ET tube correctly in place)
* Total time of high flow nasal cannula oxygen /traditional pre-oxygenation delivered
* Blood pressure
* Heart rate
* ASA classification level
* Smoker/non-smoker
* BMI
* Preoperative presence of lung condition (eg. chronic obstructive pulmonary disease (COPD), asthma) yes/no
* Preoperative oxygen therapy
* Known/treated obstructive sleep apnea (OSA) yes/no
* Type of surgery: abdominal yes/no
* Duration of surgery, hours
* Mallampati grade, thyromental distance, mouth opening and neck movement.
* Cormack \& Lehane grade
* Number of attempts to intubate
* Use of bougie during intubation yes/no
* Cricoid pressure used yes/no
* Clinical suspicion of aspiration on intubation
* Subjective experience of the pre oxygenation measured on a Visual Analogue Scale
Disruption criteria The patient doesn´t tolerate pre-oxygenation the way it is planned according to randomization.
Statistics This is a randomized controlled study evaluating a novel concept and comparing it to a traditional technique. Continuous data will be presented as mean ± SD or 95% CI and categorical data as median and range. We will analyze the data using Prism 6.0 (GraphPad) or SPSS 24 (IBM). We do not know the primary outcome parameters (lowest saturation within 1 min after intubation), but with an estimation based partly on a previous study (Wimasalena et al. Ann Emerg Med 2015) we assume that the lowest saturation in the control group will be 93% and 95% in the treatment group with a SD of 3%. Using a type I error of 5% and type II error of 20% (power 80%) a sample size of 70 patients in each group was calculated. To allow for missed data and drop-outs we plan to include 100+100 patients (total of 200 patients). After inclusion of 80 patients an interim analysis will be performed for the primary outcome. A non-paired t-test will be performed to analyse the primary outcome.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre oxygenation with 100% oxygen via tight fitting mask
Pre Oxygenation will be done using a tight mask
No interventions assigned to this group
Pre oxygenation with 100% oxygen in high-flow nasal cannula
Pre Oxygenation will be done using high-flow nasal canula
High-flow nasal cannula
Oxygenation will be done via a high-flow nasal cannula
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High-flow nasal cannula
Oxygenation will be done via a high-flow nasal cannula
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Emergency intubation where RSI is indicated
3. Capable of understanding the study information and signing the written consent.
4. Need for non-invasive ventilation
Exclusion Criteria
2. Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Malin Jonsson Fagerlund
Associate Professor, senior Consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malin Jonsson Fagerlund
Role: PRINCIPAL_INVESTIGATOR
Karolinska University Hospital and Karolinska Institutet
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRIOR
Identifier Type: -
Identifier Source: org_study_id